Engineering precision

Science Translational Medicine

Volumn 7, Issue 289, 2015, Pages

  Traverso, Giovanni ^a   Langer, Robert ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; CANCER CHEMOTHERAPY; DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; EDITORIAL; GENE THERAPY; HUMAN; MEDICAL TECHNOLOGY; NANOTECHNOLOGY; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOKINETICS; PRECISION MEDICINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TUMOR MICROENVIRONMENT; BIOMEDICAL ENGINEERING;

BIOMEDICAL ENGINEERING; HUMANS; NANOTECHNOLOGY; PRECISION MEDICINE;

EID: 84930175151     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aab1943     Document Type: Editorial

References (8)

1. R. Farra, N. F. Sheppard Jr., L. McCabe, R. M. Neer, J. M. Anderson, J. T. Santini Jr., M. J. Cima, R. Langer, First-in-human testing of a wirelessly controlled drug delivery microchip. Sci. Transl. Med. 4, 122ra21 (2012).
2. C. L. B. Kline, A. Schiccitano, J. Zhu, C. Beachler, H. Sheikh, H. A. Harvey, H. B. Mackley, K. McKenna, K. Staveley-O'Carroll, L. Poritz, E. Messaris, D. Stewart, J. Sivik, W. S. El-Deiry, Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens. Clin. Colorectal Cancer 13, 119-126 (2014).
3. S. Mura, J. Nicolas, P. Couvreur, Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991-1003 (2013).
4. R. Langer, R. Weissleder, Nanotechnology. JAMA 313, 135-136 (2015).
5. J. Hrkach, D. Von Hoff, M. M. Ali, E. Andrianova, J. Auer, T. Campbell, D. De Witt, M. Figa, M. Figueiredo, A. Horhota, S. Low, K. McDonnell, E. Peeke, B. Retnarajan, A. Sabnis, E. Schnipper, J. J. Song, Y. H. Song, J. Summa, D. Tompsett, G. Troiano, T. Van Geen Hoven, J. Wright, P. LoRusso, P. W. Kantoff, N. H. Bander, C. Sweeney, O. C. Farokhzad, R. Langer, S. Zale, Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 4, 128ra39 (2012).
6. D. M. Cutler, W. Everett, Thinking outside the pillbox - Medication adherence as a priority for health care reform. N. Engl. J. Med. 362, 1553-1555 (2010).
7. K. Ruddy, E. Mayer, A. Partridge, Patient adherence and persistence with oral anticancer treatment. CA Cancer J. Clin. 59, 56-66 (2009).
8. G. Traverso, R. Langer, Perspective: Special delivery for the gut. Nature 519, S19 (2015).